pocketful logo
Senores Pharmaceuticals Ltd logo

Senores Pharmaceuticals Ltd

NSE: SENORES BSE: 544319

₹784.25

(1.38%)

Sat, 04 Apr 2026, 08:35 am

Senores Pharmaceuticals Price to Cash Flow Ratio

Particulars2021202220232024
Price to earnings ratio00035.57
Price to book ratio0003.36
Price to sales ratio0005.24
Price to cash flow ratio0000
Enterprise value00020.38B
Enterprise value to EBITDA ratio00022.95
Debt to equity ratio0.401.381.260.40
Return on equity %020.5525.1911.82

Senores Pharmaceuticals Ltd Price to Cash Flow Ratio

The Senores Pharmaceuticals Ltd Price to Cash Flow Ratio is a key financial metric used by investors to evaluate Senores Pharmaceuticals Ltd's valuation, profitability, and overall financial performance. Tracking the Senores Pharmaceuticals Ltd Price to Cash Flow Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Senores Pharmaceuticals Ltd (NSE: SENORES, BSE: 544319) is currently trading at ₹784.25, with a market capitalization of ₹35.68B. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Senores Pharmaceuticals Ltd Price to Cash Flow Ratio is essential for fundamental analysis.

Senores Pharmaceuticals Ltd Price to Cash Flow Ratio Current Value

The current Senores Pharmaceuticals Ltd Price to Cash Flow Ratio stands at 0.

The Senores Pharmaceuticals Ltd Price to Cash Flow Ratio remains stable, indicating consistent financial performance.

Senores Pharmaceuticals Ltd Price to Cash Flow Ratio Historical Trend

The Senores Pharmaceuticals Ltd Price to Cash Flow Ratio has shown the following historical trend:

  • 2024: 0
  • 2023: 0
  • 2022: 0
  • 2021: 0

The decline in Senores Pharmaceuticals Ltd Price to Cash Flow Ratio indicates improving financial efficiency or better earnings growth.

What Senores Pharmaceuticals Ltd Price to Cash Flow Ratio Indicates for Investors

The Senores Pharmaceuticals Ltd Price to Cash Flow Ratio plays a crucial role in understanding the company's financial health and valuation.

The P/CF ratio indicates how much investors pay for company cash flow.

Senores Pharmaceuticals Ltd Price to Cash Flow Ratio Analysis Summary

The Senores Pharmaceuticals Ltd Price to Cash Flow Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Senores Pharmaceuticals Ltd Price to Cash Flow Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Senores Pharmaceuticals Ltd Price to Cash Flow Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800